309 related articles for article (PubMed ID: 35881617)
1. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
2. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
3. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
[TBL] [Abstract][Full Text] [Related]
4. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
5. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
7. Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice.
Asaka MN; Utsumi D; Kamada H; Nagata S; Nakachi Y; Yamaguchi T; Kawaoka Y; Kuba K; Yasutomi Y
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34463644
[TBL] [Abstract][Full Text] [Related]
8. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
[TBL] [Abstract][Full Text] [Related]
9. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
10. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
[TBL] [Abstract][Full Text] [Related]
11. Comparison of model-specific histopathology in mouse models of COVID-19.
Yang S; Cao L; Xu W; Xu T; Zheng B; Ji Y; Huang S; Liu L; Du J; Peng H; Zhang H; Chen J; Ke B; Zheng H; Deng X; Li C; Guo D
J Med Virol; 2022 Aug; 94(8):3605-3612. PubMed ID: 35355296
[TBL] [Abstract][Full Text] [Related]
12. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
13. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
Oladunni FS; Park JG; Pino PA; Gonzalez O; Akhter A; Allué-Guardia A; Olmo-Fontánez A; Gautam S; Garcia-Vilanova A; Ye C; Chiem K; Headley C; Dwivedi V; Parodi LM; Alfson KJ; Staples HM; Schami A; Garcia JI; Whigham A; Platt RN; Gazi M; Martinez J; Chuba C; Earley S; Rodriguez OH; Mdaki SD; Kavelish KN; Escalona R; Hallam CRA; Christie C; Patterson JL; Anderson TJC; Carrion R; Dick EJ; Hall-Ursone S; Schlesinger LS; Alvarez X; Kaushal D; Giavedoni LD; Turner J; Martinez-Sobrido L; Torrelles JB
Nat Commun; 2020 Nov; 11(1):6122. PubMed ID: 33257679
[TBL] [Abstract][Full Text] [Related]
14. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
[TBL] [Abstract][Full Text] [Related]
15. Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2.
Yu P; Deng W; Bao L; Qu Y; Xu Y; Zhao W; Han Y; Qin C
Vet Pathol; 2022 Jul; 59(4):602-612. PubMed ID: 35094625
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
[TBL] [Abstract][Full Text] [Related]
17. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of K18-
Moreau GB; Burgess SL; Sturek JM; Donlan AN; Petri WA; Mann BJ
Am J Trop Med Hyg; 2020 Sep; 103(3):1215-1219. PubMed ID: 32723427
[TBL] [Abstract][Full Text] [Related]
19. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
